COPD Therapeutics

The objective of COPD therapeutics is to improve a patient's practical status and quality by protecting optimal lung function, enhancing indications, and keeping the recurrence of COPD exacerbations. At present, no medicines aside from lung transplantation have been appeared to significantly improve lung capacity or diminishing mortality; however, oxygen treatment and smoking cessation may decrease mortality. Once the diagnosis of COPD is established, it is essential to educate the patient about the disorder and to enable their dynamic interest for treatment. Bronchodilators are the establishment of any COPD treatment regimen. They work by enlarging aviation routes, accordingly diminishing airsac protection. Pulmonary Conferences provides a podium to bring forward the novel therapies for pulmonology.

 

  • Smoking Cessation
  • Corticosteroids
  • Oxygen Therapy
  • Pulmonary Rehabilitation

Related Conference of COPD Therapeutics

March 18-19, 2020

11th Annual Congress on Pulmonology & Respiratory Medicine

Amsterdam, Netherlands
June 29-30, 2020

International Conference on Probiotics and Prebiotics

Frankfurt, Germany
October 12-13, 2020

World Congress and Expo Pulmonology

Manila, Philippines
October 12-13, 2020

International Congress and Expo on Pulmonology

Manila, Philippines
October 29-30, 2020

International Conference on Lung Diseases

Cape Town, South Africa
November 18-19, 2020

International Conference on Asthma and Allergy

Lisbon, Portugal
December 7-8, 2020

8th Annual Congress on Pulmonary and Critical Care

Tokyo, Japan

COPD Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in